logo
HomeArticlesAbout
Register | Login
Review
Folia Medica 64(5): 725-732
https://doi.org/10.3897/folmed.64.e65693 (31 Oct 2022)
Other versions:
XML
PDF
cart
 
 
Twitter
Facebook
Mendeley
Reddit
Notify a colleague
  • ContentsContents
  • Article InfoArticle Info
  • CitationCitation
  • MetricsMetrics
  • CommentComment
  • RelatedRelated
  • FigsFigs
  • TabsTabs
  • RefsRefs
  • CitedCited
  • Article title
  • Abstract
  • Keywords
  • Introduction
    • Significance of pharmacoeconomic assessment
    • Costs attributed to GDM
    • Direct cost associated with GDM
    • Direct non-medical cost associated with GDM
    • Indirect costs
    • Intangible costs
    • Cost-effectiveness of GDM screening including prevention of T2DM
    • Short-term cost of GDM
    • Costs and benefits of GDM treatment
    • Bulgarian experience with pharmacoeconomic studies associated with GDM
  • Conclusions
  • References
Powered by

This website uses cookies in order to improve your web experience. Read our Cookies Policy

OK